PUBLISHER: The Business Research Company | PRODUCT CODE: 2112333
PUBLISHER: The Business Research Company | PRODUCT CODE: 2112333
Polysomnography systems are medical diagnostic devices designed to track and record a variety of physiological functions during sleep, including brain activity, eye movements, muscle activity, heart rate patterns, respiratory functions, and blood oxygen levels. Their primary application is the identification and assessment of sleep disorders such as sleep apnea, insomnia, narcolepsy, and other neurological or breathing-related sleep conditions.
The primary product categories of polysomnography systems include fixed polysomnography systems and portable polysomnography systems. Fixed polysomnography systems are comprehensive sleep assessment solutions installed within clinical facilities for detailed monitoring of sleep-related parameters. These systems incorporate technologies such as wired systems, wireless systems, and cloud-based sleep monitoring systems. Their major applications include sleep apnea, narcolepsy, rapid eye movement sleep behavior disorder, restless legs syndrome, and other conditions, while their end users include hospitals, sleep centers, homecare settings, and others.
Tariffs are influencing the polysomnography systems market by increasing the cost of imported sleep monitoring equipment, sensors, electrodes, and data acquisition systems used for accurate sleep disorder diagnosis. This is delaying procurement in hospitals, sleep centers, and homecare settings, particularly in import-dependent regions like Asia-Pacific and Latin America where healthcare infrastructure expansion is ongoing. Advanced segments such as wireless and cloud-based polysomnography systems are most affected due to dependence on semiconductor-driven components and specialized medical electronics. However, tariffs are also encouraging local production of diagnostic devices, diversification of supply chains, and greater investment in domestic medical technology ecosystems, supporting long-term market resilience.
The polysomnography systems market size has grown steadily in recent years. It will grow from $1.44 billion in 2025 to $1.51 billion in 2026 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to limited awareness of sleep disorders, reliance on hospital-based sleep laboratories, increasing diagnosis of sleep apnea cases, growth in polysomnography equipment adoption in developed healthcare systems, manual and labor-intensive sleep study analysis.
The polysomnography systems market size is expected to see steady growth in the next few years. It will grow to $1.79 billion in 2030 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to rising prevalence of sleep-related breathing disorders, increasing adoption of home sleep testing solutions, expansion of telehealth and remote patient monitoring, technological advancements in wearable sleep diagnostic devices, growing healthcare expenditure on neurological and respiratory diagnostics. Major trends in the forecast period include rising adoption of home-based sleep monitoring and portable diagnostic devices, increasing demand for wireless and cloud-connected sleep study systems, growing prevalence of sleep apnea and neurological sleep disorders, expansion of sleep clinics and specialized diagnostic centers, increasing integration of multi-channel physiological monitoring for comprehensive sleep analysis.
The increasing prevalence of sleep disorders is expected to drive the growth of the polysomnography systems market in the coming years. Sleep disorders are medical conditions that disrupt normal sleep patterns, duration, quality, or breathing during sleep and negatively affect physical and mental health. The rising prevalence of sleep disorders is primarily driven by chronic stress and irregular lifestyles, as prolonged stress, shift work, and screen exposure disrupt normal circadian rhythms and sleep architecture. Polysomnography (PSG) systems are used in the diagnosis and evaluation of sleep disorders by continuously recording multiple physiological signals during sleep, including brain activity (EEG), eye movements, heart rate, breathing effort, airflow, and blood oxygen levels. For instance, in January 2026, according to the National Library of Medicine (NLM), a US-based biomedical library and research institution, among individuals aged 40-59 years, the rate of diagnosed sleep disorders (G47) as the primary condition increased from 334.0 per 100,000 population in 2023 to 362.8 per 100,000 in 2024. Therefore, the increasing prevalence of sleep disorders is driving the growth of the polysomnography systems market.
Key companies operating in the polysomnography systems market are focusing on developing advanced solutions, such as AI-powered sleep staging software, to enhance diagnostic accuracy, streamline sleep study analysis, and improve clinical workflow efficiency. AI-powered sleep staging software refers to artificial intelligence-based technology that automatically analyzes physiological signals from polysomnography recordings to classify sleep stages and support the diagnosis of sleep disorders. For example, in March 2024, Beacon Biosignals, a US-based neurodiagnostics technology company, received U.S. FDA 510(k) clearance for SleepStageML, an artificial intelligence-enabled sleep analysis solution designed for use with clinical polysomnography recordings. The software expands Beacon's sleep analysis capabilities by automating sleep staging and supporting comprehensive analysis of traditional in-lab polysomnography studies, helping clinicians improve diagnostic workflows and accelerate sleep disorder assessment.
In April 2025, Beacon Biosignals Inc., a US-based neurotechnology company, acquired Cleveland Medical Devices Inc. for an undisclosed amount. Through this acquisition, Beacon Biosignals strengthened its home sleep testing and polysomnography ecosystem by integrating Cleveland Medical Devices' sleep diagnostic hardware and services with its AI-driven sleep analysis platform, enabling more comprehensive sleep disorder assessment and expanding its end-to-end sleep monitoring capabilities. Cleveland Medical Devices Inc. is a US-based medical devices company specializing in neurodiagnostic and polysomnography (PSG) sleep monitoring systems used for sleep disorder diagnosis and analysis.
Major companies operating in the polysomnography systems market are Koninklijke Philips N.V.; ResMed Inc.; Nihon Kohden Corporation; SOMNOmedics GmbH; Compumedics Limited; Nox Medical; Lowenstein Medical Technology; Cadwell Industries; Neurovirtual; MGC Diagnostics Corporation; BMC Medical Co. Ltd.; Onera Health; Recorders & Medicare Systems Pvt. Ltd.; Neurosoft Ltd.; CIDELEC; Allengers Medical Systems Limited; Braebon Medical Corporation; CleveMed; Bittium Biosignals Ltd.
North America was the largest region in the polysomnography systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polysomnography systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the polysomnography systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The polysomnography systems market consists of sales of sleep monitoring systems, electroencephalography recording systems, portable sleep testing systems, wireless sleep monitoring devices, and multi-parameter sleep diagnostic equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The polysomnography systems market research report is one of a series of new reports from The Business Research Company that provides polysomnography systems market statistics, including polysomnography systems industry global market size, regional shares, competitors with a polysomnography systems market share, detailed polysomnography systems market segments, market trends and opportunities, and any further data you may need to thrive in the polysomnography systems industry. This polysomnography systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Polysomnography Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses polysomnography systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for polysomnography systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polysomnography systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.